Research Analysts Issue Forecasts for CareCloud Q2 Earnings

CareCloud, Inc. (NASDAQ:CCLD) – Research analysts at Zacks Research issued their Q2 2026 earnings estimates for CareCloud in a research note issued on Thursday, March 12th. Zacks Research analyst M. Kim forecasts that the company will earn $0.11 per share for the quarter. The consensus estimate for CareCloud’s current full-year earnings is $0.58 per share. Zacks Research also issued estimates for CareCloud’s Q3 2026 earnings at $0.12 EPS, Q4 2026 earnings at $0.12 EPS, FY2026 earnings at $0.45 EPS and FY2027 earnings at $0.53 EPS.

CareCloud (NASDAQ:CCLD) last issued its quarterly earnings data on Thursday, March 12th. The company reported $0.11 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.11. CareCloud had a return on equity of 24.96% and a net margin of 8.96%.The firm had revenue of $34.42 million during the quarter, compared to the consensus estimate of $32.10 million. CareCloud has set its FY 2026 guidance at 0.200-0.23 EPS.

CCLD has been the subject of several other research reports. Wall Street Zen upgraded shares of CareCloud from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 14th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CareCloud in a report on Monday, December 29th. Finally, ThinkEquity assumed coverage on CareCloud in a research report on Monday, November 24th. They set a “buy” rating for the company. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $3.25.

CareCloud Price Performance

Shares of NASDAQ:CCLD opened at $3.14 on Friday. The stock has a market cap of $133.14 million, a PE ratio of 39.25 and a beta of 2.09. The business’s fifty day moving average price is $2.68 and its two-hundred day moving average price is $3.05. CareCloud has a one year low of $1.14 and a one year high of $4.01. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.24 and a current ratio of 1.26.

Hedge Funds Weigh In On CareCloud

Several large investors have recently bought and sold shares of CCLD. Acadian Asset Management LLC lifted its stake in shares of CareCloud by 481.9% in the 1st quarter. Acadian Asset Management LLC now owns 203,053 shares of the company’s stock worth $280,000 after acquiring an additional 168,156 shares during the period. Prospera Financial Services Inc boosted its stake in CareCloud by 31.8% during the 2nd quarter. Prospera Financial Services Inc now owns 75,966 shares of the company’s stock valued at $179,000 after purchasing an additional 18,339 shares in the last quarter. Geode Capital Management LLC boosted its stake in CareCloud by 235.4% during the 2nd quarter. Geode Capital Management LLC now owns 359,486 shares of the company’s stock valued at $848,000 after purchasing an additional 252,299 shares in the last quarter. Hillsdale Investment Management Inc. increased its position in shares of CareCloud by 61.8% during the 2nd quarter. Hillsdale Investment Management Inc. now owns 130,900 shares of the company’s stock valued at $309,000 after purchasing an additional 50,000 shares during the period. Finally, American Century Companies Inc. acquired a new position in shares of CareCloud during the 2nd quarter valued at $78,000. Institutional investors and hedge funds own 10.16% of the company’s stock.

Key Stories Impacting CareCloud

Here are the key news stories impacting CareCloud this week:

• Positive Sentiment: CareCloud reported record net income and its first full-year positive EPS since IPO, said it exceeded revenue guidance, and introduced new generative AI products — a fundamental update that supports growth and margin narrative. Read More.
• Positive Sentiment: Q4 revenue beat consensus ($34.42M vs. $32.10M) and EPS matched estimates at $0.11, signaling revenue momentum even as year-over-year EPS fell; management provided supplemental materials (press release/slide deck) for investors. Read More.
• Positive Sentiment: Zacks Research raised its FY2026 EPS forecast (from $0.43 to $0.45) and published updated quarterly/FY2027 estimates, reflecting analyst model adjustments after the results. Read More.
• Neutral Sentiment: Zacks published detailed quarterly estimates (Q2–Q4 2026 and FY2027), which give investors a roadmap for expected cadence but do not materially change consensus yet. Read More.
• Neutral Sentiment: Reported short-interest data in recent feeds shows anomalous “0 shares / NaN” entries; the published short-interest figures appear unreliable and should be treated cautiously. (Data items from March filings showed inconsistent values.)
• Negative Sentiment: CareCloud set FY2026 EPS guidance at $0.20–$0.23, below the consensus (~$0.24), and gave revenue guidance of $128–$132M (vs. consensus ~$130.6M) — the lower EPS range is a headwind that likely tempered some investor enthusiasm. Read More.

CareCloud Company Profile

CareCloud, Inc is a healthcare technology company that provides cloud-based practice management, electronic health record (EHR) and revenue cycle management (RCM) solutions to medical practices and health systems. Its flagship offering, the CareCloud Central platform, combines clinical, financial and administrative workflows into a single, unified system. The platform includes modules for scheduling, billing, coding, patient engagement and telehealth, enabling practices to streamline front- and back-office operations and improve overall practice performance.

Founded in 2009 and headquartered in Miami Beach, Florida, CareCloud serves small to mid-size physician groups and specialty clinics across the United States.